Applications close on 21 October 2026. The BIRAC-PATH Patent Facilitation programme is now open, offering biotech innovators structured, end-to-end support for protecting their intellectual property — in India and internationally.
Run by the Biotechnology Industry Research Assistance Council (BIRAC), an initiative of the Department of Biotechnology, Government of India, the programme is aimed squarely at the biggest hidden cost in biotech entrepreneurship: the money, time and procedural maze of securing patents. For a lab-stage startup, filing internationally can cost more than a year's R&D budget — and a misstep in the process can sink a company before it ships.
PATH connects innovators with empaneled IP and Technology Transfer firms, providing strategic guidance across the stages of the patenting process. The emphasis is on making IP protection — an essential step for commercialisation — less financially and procedurally daunting for early-stage biotech ventures and academic innovators.
This is a subsidy-style support programme rather than a cash prize, which is worth understanding: the value comes in professional services and strategic guidance that would otherwise be paid for at market rates. For biotech founders, deep-tech researchers and university spinouts with patentable work, that can be the difference between filing and not filing.
The programme was listed as newly launched this week. Innovators with biotech IP in the pipeline should apply before the 21 October 2026 deadline — and treat the IP strategy conversation as seriously as the application itself.
Why it matters for founders
In biotech, the patent is the product — investors fund IP portfolios, not just teams. Yet most Indian biotech founders under-file because the process is expensive and opaque. BIRAC-PATH directly attacks that gap. If your startup has patentable biotech innovation, the 21 October deadline is worth your weekend.